VBI Vaccines Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was USD 0.72 million compared to USD 0.346 million a year ago. Net loss was USD 44.63 million compared to USD 45.7 million a year ago. Basic loss per share from continuing operations was USD 5.18 compared to USD 5.31 a year ago.
For the six months, sales was USD 1.21 million compared to USD 0.472 million a year ago. Net loss was USD 72.38 million compared to USD 66.95 million a year ago. Basic loss per share from continuing operations was USD 8.41 compared to USD 7.78 a year ago.